A widely available drug used to treat alcoholism has potential as a COVID-19 treatment, researchers say. The investigators found that people taking disulfiram (Antabuse) for alcoholism had a lower risk of infection with SARS-CoV-2 and were less likely to die from COVID-19 if infected than those not taking the drug. The study was observational, so…  read on >  read on >

A new study is highlighting yet another consequence of the COVID-19 pandemic: It has likely made it even harder for kids with obesity to manage their weight. The findings, researchers said, are no surprise. Many adults, faced with normal life being upended during the pandemic, have seen changes on the bathroom scale. It’s also clear…  read on >  read on >

It’s probably fair to say that most people know of the so-called “Freshman 15” — the weight that college students are often said to gain when they’re away from home for the first time. But in recent decades, matters have gotten much worse in the United States. A new study using national data for people…  read on >  read on >

Guidelines for treating movement problems in people in the early stages of Parkinson’s disease have been updated. The new treatment recommendations from the American Academy of Neurology (AAN) focus on dopaminergic medications, which increase dopamine levels or mimic dopamine effects. Parkinson’s is a movement disorder that occurs when nerve cells in the brain fail to…  read on >  read on >

Neurologists must make sure Alzheimer’s patients and their families understand that the controversial drug aducanumab does not restore mental function, the American Academy of Neurology (AAN) said in new position statement that includes ethical guidelines. “Aducanumab is not a cure for Alzheimer’s disease, yet since it has been approved by the [U.S. Food and Drug…  read on >  read on >